RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ARYx Therapeutics Stock

ARYx Therapeutics Market capitalization 2024

ARYx Therapeutics Market capitalization

27.44 USD

Ticker

ARYX

ISIN

US0433871094

In 2024, ARYx Therapeutics's market cap stood at 27.44 USD, a -99.99% increase from the 221,561.85 USD market cap in the previous year.

The ARYx Therapeutics Market capitalization history

YEARMarket Capitalization (undefined USD)
200988.95
2008107.7
2007138.79
2006-
2005-
2004-
2003-
2002-

ARYx Therapeutics Aktienanalyse

What does ARYx Therapeutics do?

ARYx Therapeutics Inc is a pharmaceutical company founded in 1997 and based in Fremont, California. The company focuses on developing innovative patented therapies for the treatment of heart diseases and other metabolic diseases. The company's business model is based on recognizing the need for new and more effective medications and focusing on the discovery and development of such therapies. ARYx Therapeutics relies on a network of experienced professionals and a rigorous research and development program. ARYx Therapeutics has several divisions, including the development of therapies for the treatment of cardiac arrhythmias, as well as metabolic diseases such as diabetes and hypercholesterolemia. In addition, the company has developed a range of products that interact with the body in innovative ways by activating or blocking specific receptors. ARYx Therapeutics' most well-known product is the antiarrhythmic drug Dronedaron. It is the first antiarrhythmic drug to receive the safety standards of the US Food and Drug Administration (FDA) and offers an effective, safe, and well-tolerated treatment for atrial fibrillation. Dronedaron is currently approved in Europe and the US and is used worldwide by doctors and hospitals as an important treatment option. Another successful product from ARYx Therapeutics is the therapeutic agent NTP-2007. It was developed to increase insulin sensitivity and improve blood sugar control in patients with type 2 diabetes. NTP-2007 utilizes a novel mechanism that enhances the effect of insulin in the body without lowering blood sugar levels. It is currently being tested in clinical trials and showing promising results. Another promising product from ARYx Therapeutics is the anesthetic Fexinidazole. It is an innovative anesthetic that works in a unique way in the body and ensures fast and effective anesthesia without causing negative side effects. Fexinidazole is currently being tested in clinical trials and could prove to be an important innovation in anesthesiology. Overall, ARYx Therapeutics has established itself as a leading company in the research and development of innovative therapies for the treatment of heart diseases and metabolic diseases. The company aims to meet the needs of patients and medical professionals and improve global healthcare by pushing the boundaries of science and technology in medicine. ARYx Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring ARYx Therapeutics's Market Capitalization

ARYx Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of ARYx Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

ARYx Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in ARYx Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about ARYx Therapeutics stock

What is the current ARYx Therapeutics market capitalization?

The current market capitalization of ARYx Therapeutics is 27.44 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like ARYx Therapeutics.

How has the market capitalization of ARYx Therapeutics developed in recent years?

The market capitalization of ARYx Therapeutics has increased/decreased by -99.99% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of ARYx Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of ARYx Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of ARYx Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does ARYx Therapeutics pay?

Over the past 12 months, ARYx Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ARYx Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of ARYx Therapeutics?

The current dividend yield of ARYx Therapeutics is .

When does ARYx Therapeutics pay dividends?

ARYx Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ARYx Therapeutics?

ARYx Therapeutics paid dividends every year for the past 0 years.

What is the dividend of ARYx Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ARYx Therapeutics located?

ARYx Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von ARYx Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ARYx Therapeutics from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did ARYx Therapeutics pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of ARYx Therapeutics in the year 2023?

In the year 2023, ARYx Therapeutics distributed 0 USD as dividends.

In which currency does ARYx Therapeutics pay out the dividend?

The dividends of ARYx Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ARYx Therapeutics

Our stock analysis for ARYx Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ARYx Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.